What question did this study set out to answer?

Synthesize current knowledge on the role of Wnt/beta-catenin signaling in cancer stem cells and evaluate the therapeutic feasibility of targeting this pathway.

June 9, 2010Clinical Cancer ResearchOpen Access

Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?

View Full Paper

Ask AI

Bookmark

Authors

FTFumi Takahashi‐YanagaUniversity of Occupational and Environmental Health Japan MKMichaël KahnCity of Hope

Discussion

Member takes

Implication

Perspective review explores Wnt/beta-catenin pathway dynamics in cancer stem cells, highlighting therapeutic opportunities and safety challenges for targeted cancer eradication.

Key Points

Synthesize current knowledge on the role of Wnt/beta-catenin signaling in cancer stem cells and evaluate the therapeutic feasibility of targeting this pathway.
Reviewed evolutionary conservation and physiological functions of Wnt pathways across embryonic development and adult tissue homeostasis.
Evaluated the molecular overlaps between normal somatic stem cell niches and cancer stem cells in tissues such as skin, blood, intestine, and brain.
Wnt/beta-catenin signaling critically governs cell proliferation, morphology, motility, and cell fate decisions in both healthy tissues and neoplasms.
Extensive molecular similarities between normal adult stem cells and cancer stem cells pose significant challenges for selective therapeutic targeting without dose-limiting toxicities.
Outlined strategic avenues for developing selective therapeutics capable of disrupting Wnt-driven oncogenesis while preserving homeostatic tissue maintenance.

Cite This Study

Takahashi‐Yanaga et al. (2010) studied this question.

synapsesocial.com/papers/6a8b9768ae714cd733ca9bf5 https://doi.org/10.1158/1078-0432.ccr-09-2943

View Full Paper

Ask AI

Bookmark

June 9, 2010Clinical Cancer ResearchOpen Access

Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?

View Full Paper

Ask AI

Bookmark

Authors

FTFumi Takahashi‐YanagaUniversity of Occupational and Environmental Health Japan MKMichaël KahnCity of Hope

Discussion

Member takes

Implication

Perspective review explores Wnt/beta-catenin pathway dynamics in cancer stem cells, highlighting therapeutic opportunities and safety challenges for targeted cancer eradication.

Key Points

Synthesize current knowledge on the role of Wnt/beta-catenin signaling in cancer stem cells and evaluate the therapeutic feasibility of targeting this pathway.
Reviewed evolutionary conservation and physiological functions of Wnt pathways across embryonic development and adult tissue homeostasis.
Evaluated the molecular overlaps between normal somatic stem cell niches and cancer stem cells in tissues such as skin, blood, intestine, and brain.
Wnt/beta-catenin signaling critically governs cell proliferation, morphology, motility, and cell fate decisions in both healthy tissues and neoplasms.
Extensive molecular similarities between normal adult stem cells and cancer stem cells pose significant challenges for selective therapeutic targeting without dose-limiting toxicities.
Outlined strategic avenues for developing selective therapeutics capable of disrupting Wnt-driven oncogenesis while preserving homeostatic tissue maintenance.

Cite This Study

Takahashi‐Yanaga et al. (2010) studied this question.

synapsesocial.com/papers/6a8b9768ae714cd733ca9bf5 https://doi.org/10.1158/1078-0432.ccr-09-2943

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark